Heartflow Inc (HTFL)

Currency in USD
30.77
+0.92(+3.08%)
Closed·
36.15+5.14(+16.58%)
·
Unusual Post-Market activity
Earnings results expected today
HTFL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.2731.72
52 wk Range
20.1341.22
Key Statistics
Prev. Close
29.85
Open
29.79
Day's Range
29.27-31.72
52 wk Range
20.13-41.22
Volume
1.43M
Average Volume (3m)
1.47M
1-Year Change
-7.4308%
Book Value / Share
3.33
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
HTFL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
36.63
Upside
+19.03%
Members' Sentiments
Bearish
Bullish
ProTips
Significant return over the last week

Heartflow Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 36.63
(+19.03% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Baird
Buy34.00+10.50%-New CoverageJul 31, 2026
Stifel
Buy40.00+30.00%-MaintainJul 15, 2026
Freedom Broker
Buy37.00+20.25%-New CoverageJul 08, 2026
Freedom Capital
Buy37.00+20.25%-New CoverageJun 30, 2026
Piper Sandler
Buy38.00+23.50%-MaintainJun 11, 2026

Heartflow Inc Earnings Call Summary for Q2/2026

  • HeartFlow posted Q2 adjusted EPS of -$0.07, beating estimates of -$0.19 by 63%; revenue surged 48% YoY to $64.1M, driving shares up 17% after-hours.
  • Gross margin expanded 770 bps to 83.3% from AI automation and volume leverage; plaque revenue hit $7.8M, $4M above expectations with record physician orders.
  • Company raised FY 2026 guidance to $246M-$250M revenue (40-42% growth), 82% gross margin, and expects cash flow profitability by mid-2028.
  • CEO cited accelerating momentum across core FFRCT and plaque businesses; new Plaque Staging launched July, PCI Navigator gaining traction, Plaque Tracker due 2027.
  • Risks include ongoing losses, 96% opex-to-revenue ratio, reimbursement dependence, and litigation; asymptomatic patient trials could expand addressable market to $11B.
Last Updated: 2026-08-13, 06:06 p/m
Read Full Transcript

Earnings

Latest Release
Aug 13, 2026
EPS / Forecast
-0.07 / -0.19
Revenue / Forecast
64.08M / --
EPS Revisions
Last 90 days

HTFL Income Statement

Compare HTFL to Peers and Sector

Metrics to compare
HTFL
Peers
Sector
Relationship
P/E Ratio
−23.7x−0.3x−0.3x
PEG Ratio
−0.260.020.00
Price/Book
9.3x2.0x2.6x
Price / LTM Sales
13.9x1.7x3.1x
Upside (Analyst Target)
24.0%5.7%48.3%
Fair Value Upside
Unlock20.5%6.7%Unlock

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the United States and worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient’s heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart’s arteries. The company provides Heartflow RoadMap Analysis that offers an intuitive anatomic visualization of the coronary arteries; Heartflow FFRCT Analysis, which calculates blood flow and pinpoints clinically; and Heartflow Plaque Analysis that provides a comprehensive assessment of coronary plaque, enabling optimized medical treatment strategies. Its platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. HeartFlow, Inc. was formerly known as Cardiovascular Simulation, Inc. and changed its name to HeartFlow, Inc. in May 2009. The company was incorporated in 2007 and is headquartered in San Francisco, California.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
34.93M40.50%1.04B
Other Institutional Investors
57.90M59.50%1.73B
Public Companies & Retail Investors
0.000.00%0.00
Total
92.82M100.00%2.77B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Wellington Management Group LLP13.89%11,982,283357,671
Bain Capital Life Sciences Investors, LLC9.80%8,448,158252,178

People Also Watch

134.43
APGE
-0.09%
63.24
LGN
-7.92%
17.860
ERAS
-3.88%
67.08
MBX
+0.16%
23.81
JBIO
+2.56%

FAQ

What Is the Heartflow (HTFL) Stock Price Today?

The Heartflow stock price today is 30.77 USD.

What Stock Exchange Does Heartflow Trade On?

Heartflow is listed and trades on the Nasdaq Stock Exchange.

What Is the Stock Symbol for Heartflow?

The stock symbol for Heartflow is "HTFL."

What Is the Heartflow Market Cap?

As of today, Heartflow market cap is 2.57B USD.

What Is Heartflow's Earnings Per Share (TTM)?

The Heartflow EPS (TTM) is -1.97.

When Is the Next Heartflow Earnings Date?

Heartflow will release its next earnings report on Aug 13, 2026.

From a Technical Analysis Perspective, Is HTFL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Heartflow Stock Split?

Heartflow has split 0 times.

How Many Employees Does Heartflow Have?

Heartflow has 843 employees.

What is the current trading status of Heartflow (HTFL)?

As of Aug 13, 2026, Heartflow (HTFL) is trading at a price of 30.77 USD, with a previous close of 29.85 USD. The stock has fluctuated within a day range of 29.27 USD to 31.72 USD, while its 52-week range spans from 20.13 USD to 41.22 USD.

What Is Heartflow (HTFL) Price Target According to Analysts?

The average 12-month price target for Heartflow is 36.63 USD, with a high estimate of 40 USD and a low estimate of 34 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +19.03% Upside potential.

What Is the HTFL Premarket Price?

HTFL's last pre-market stock price is 30.30 USD. The pre-market share volume is 1,600.00, and the stock has decreased by 0.45, or 1.51%.

What Is the HTFL After Hours Price?

HTFL's last after hours stock price is 36.15 USD, the stock has decreased by 5.14, or 16.58%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.